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Type II cells are the defenders of the alveolus. They produce surfactant to prevent alveolar collapse, they
actively transport water to prevent filling of the air sacs that would otherwise prevent gas exchange, and they
differentiate to type I epithelial cells. They are an indispensable component of functional lung tissue. To
understand the functionality of type II cells in isolation, we sought to track their fate in decellularized matrices
and to assess their ability to contribute to barrier function by differentiation to type I alveolar epithelial cells.
Rat type II cells were isolated from neonatal rat lungs by labeling with the RTII-70 surface marker and
separation using a magnetic column. This produced a population of *50% RTII-70-positive cells accompanied
by few type I epithelial cells or a-actin-positive mesenchymal cells. This population was seeded into decellularized
rat lung matrices and cultured for 1 or 7 days. Culture in Dulbecco’s modified Eagle’s medium +10% fetal bovine
serum (FBS) resulted in reduced expression of epithelial markers and increased expression of mesenchymal
markers. By 7 days, no epithelial markers were visible by immunostaining; nearly all cells were a-actin positive.
Gene expression for the mesenchymal markers, a-actin, vimentin, and TGF-bR, was significantly upregulated on
day 1 ( p = 0.0005, 0.0005, and 2.342E-5, respectively). Transcript levels of a-actin and TGF-bR remained high at 7
days ( p = 1.364E-10 and 0.0002). Interestingly, human type II cells cultured under the same conditions showed a
similar trend in the loss of epithelial markers, but did not display high expression of mesenchymal markers. Rat
cells additionally showed the ability to produce and degrade the basement membrane and extracellular matrix
components, such as fibronectin, collagen IV, and collagen I. Quantitative real-time reverse transcription poly-
merase chain reaction (RT-PCR) showed significant increases in expression of the fibronectin and matrix me-
talloprotease-2 (MMP-2) genes after 1 day in culture ( p = 0.0135 and 0.0128, respectively) and elevated collagen I
expression at 7 days ( p = 0.0016). These data suggest that the original type II-enriched population underwent
a transition to increased expression of mesenchymal markers, perhaps as part of a survival or wound-healing
program. These results suggest that additional medium components and/or the application of physiologically
appropriate stimuli such as ventilation may be required to promote lung-specific epithelial phenotypes.
Introduction
In recent years, several laboratories have reported therepopulation of decellularized lung matrices with mixed
populations of differentiated cells or with precursor-derived
or stem cell-derived cells.1–7 Previous data indicate the
ability of a mixed population of rat neonatal lung cells to
repopulate an acellular lung extracellular matrix (ECM)
scaffold in a regionally specific manner. When a decellular-
ized lung ECM scaffold was seeded with a mixed population
of neonatal lung cells, pro-surfactant protein-C (pro-SPC)-
positive type II epithelial cells tended to locate in the vertices
of the alveoli with morphologically appropriate expression of
pro-SPC; they were generally not found in more proximal
airway structures.2
When provided with breathing movements inside of a
bioreactor, the mixed neonatal cells also were able to pop-
ulate the alveoli with type I pneumocytes and the proximal
airways with appropriate proximal lung epithelial cell types,
including club cells and rare basal cells. To understand the
localization and differentiation capacity of a single cell type
from the previous mixed populations, we enriched for type
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II alveolar epithelial cells from a mixed rat epithelial pop-
ulation. We evaluated the capacity of the type II population
to adhere to, proliferate within, and reconstitute the alveoli
in vitro. Type II cells serve the critical functions of sur-
factant production, alveolar fluid transport, and differentia-
tion to type I cells. Indeed, work by Lwebuga-Mukasa et al.,
wherein isolated rat type II cells were cultured on slices of
decellularized human lung matrix in vitro, suggested that
type II cells would undergo a transition to a type I alveolar
epithelial-like phenotype, as assessed by morphological
changes observed with electron microscopy.8
In this study, we describe the isolation of a distal lung
epithelial cell population that is enriched for RTII-70-positive
cells and the subsequent seeding and cultivation of these cells
in decellularized lung scaffolds. RTII-70 is a surface marker
of type II epithelial cells in the adult rat lung9 and has been
used successfully to isolate nearly pure populations of RTII-
70 + cells through fluorescence-activated cell sorting (FACS).10,11
The cell populations isolated here, from neonatal rat pups
that were 7–10 days old, were *50% positive for RTII-70 and
most of these cells were also positive for the type II pneumocyte
marker, pro-SPC.
Our data show that this RTII-70 + population was able to
adhere to the matrix after seeding onto the scaffolds and
spending 1 day in culture. These cells persist within the
scaffold for at least 7 days. Immunostaining and polymerase
chain reaction (PCR) data indicate a significant decline in the
RTII-70 marker that was used to enrich the isolate as well as
other alveolar epithelial markers, such as pro-SPC and AQP-
5, with increased time in culture. There was a concomitant
increase in mesenchymal markers such as a-actin and vi-
mentin over the course of 7 days. Expression of genes for
collagen I, fibronectin, matrix metalloprotease-2 (MMP-2),
and TGF-b receptor I also increased between seeding time
and after 1 week in culture. Taken together, these data sug-
gest that the cells take on a migratory, contractile, and matrix-
secreting phenotype atypical of epithelial cells.
The data collected in these studies suggest that the alveolar
epithelial cells that are isolated and cultured in a bioreactor in
the presence of FBS undergo an epithelial-to-mesenchymal
transition, likely as a part of the wound healing required to
repopulate an acellular matrix in the presence of serum. This
is a somewhat surprising finding since mixed populations of
neonatal rat cells, on the same scaffold and in the same se-
rum-containing media, do not demonstrate this type of tran-
sition. This suggests that mixtures of cell types, especially if
they include niche-supporting mesenchymal cells, may in fact
result in retention of epithelial phenotype better than type II
cells cultured in relative isolation.
Materials and Methods
All animal work was done in accordance with AAALAC
and AVMA guidelines and was approved by the Yale IACUC.
Lung decellularization and scaffold preparation
Lungs were obtained from anesthetized 3–4-month-old
adult Fischer 344 rats as previously described.12 Briefly, lungs
were cleared of blood in situ, and the lungs, heart, and trachea
were removed en bloc. The pulmonary artery and trachea were
cannulated, and lungs were mounted in a bioreactor for de-
cellularization. After treatment with 500 mL of decellulariza-
tion solution containing 8 mM CHAPS, lungs were inflated
with benzonase endonuclease (90 U/mL), incubated for 1 h at
37C, and rinsed extensively with phosphate-buffered saline
(PBS). Lungs were then perfused with antibiotics/antimycotics
for up to 72 h at room temperature and stored at 4C until use.
In preparation for seeding, lungs were removed from the
bioreactor in a sterile manner. The left lung and three of
the four lobes of the right lung were removed, leaving only
the upper right lobe connected to the trachea and pulmonary
artery. The lobe was then replaced into the bioreactor for
seeding with isolated lung cells.
Rat distal lung epithelial cell isolation
Cells were isolated according to a protocol adapted from
Rice et al.13 Seven-day-old Sprague-Dawley rat pups were
euthanized by IP injection of sodium pentobarbital (150 mg/
kg). Then, the chest plate was removed, the apex of the heart
severed, and the lungs cleared of blood with 100 U/mL heparin
in PBS. The trachea was dissected out and cannulated with a
24 G, 0.75-in I.V. catheter. The lungs were inflated with 1.0–
1.5 mL dispase (2 U/mL) in Dulbecco’s modified Eagle’s
medium (DMEM) with 20% HBSS, followed by *0.5 mL of
1% low-melting-point agarose. The lungs were covered with
ice to allow the agarose to gel, and then the lungs were re-
moved from the chest and incubated with additional dispase
solution (1 mL/set of lungs) for 45 min at room temperature.
After incubation, lungs were transferred to a Petri dish
containing DMEM with 1% HEPES and 100 U/mL DNAse
I. In this study, the lung tissue was teased apart and the
mainstem bronchi removed. The remaining tissue was
minced, then dissociated with a blunt bone marrow aspi-
ration needle. The homogenized tissue was then filtered
with 100- and 40-mm cell strainers and through a 20-mm
mesh and treated with antibiotics/antimycotics. The cell
suspension was centrifuged and partitioned for cell label-
ing and positive selection.
Positive cell selection with RTII-70
monoclonal antibody
Suspended cells were labeled with RTII-70 antibody at
1:40 dilution.9 After incubating with primary antibody for
30 min at room temperature in DMEM with 2 mM EDTA
and 0.5% BSA (hereafter, labeling buffer), labeled cells
were washed and incubated with anti-mouse IgG super-
paramagnetic microbeads from Miltenyi Biotec for 25 min
at 4C. Labeled and tagged cells were washed and re-
suspended in 500 mL of labeling buffer per 60 million cells.
MS columns were positioned in a magnetic field and rinsed
with 500mL of labeling buffer. Five hundred microliters of
cell suspension was then applied to each column. Columns
were subsequently rinsed with additional labeling buffer,
then removed from the magnet, and flushed to obtain the
positively selected RTII-70-positive labeled cells.
Bioreactor seeding and culture of RTII-70 + cells
in mounted decellularized matrices
Immediately after isolation and positive selection, 10
million cells were introduced to the upper right lobe of the
decellularized lung that was mounted in the bioreactor. Cells
were injected into the lobe using a 3-mL syringe containing
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1.5 mL of cells suspended in DMEM + 10% fetal bovine
serum (FBS) + 1% penicillin/streptomycin (hereafter referred
to as culture medium). The injection was followed by a slow
infusion of media into the lobe through the airways. The
infusion was the result of generating negative pressure in the
main bioreactor chamber with a syringe pump. The pump
removed a total of 30 mL of air from the main bioreactor jar,
which allowed the lung to fill with media from the trachea
reservoir. The syringe pump removed air at 2 mL/min.
Lungs remained static (no perfusion, no ventilation)
overnight at 37C and 5% CO2. Pulsatile perfusion of 1 mL/
min was initiated 16–24 h after seeding and continued for
the remainder of the culture period.
Bioreactor seeding and culture of human type II cells
in mounted decellularized matrices
Human type II epithelial cells were obtained from Dr. Peter
Bove at the University of North Carolina (Chapel Hill, NC)
and have been previously characterized.14 Decellularized
lungs were prepared as described and the upper right lobe,
connected to the trachea, was mounted in the bioreactor for
seeding and culture. A total of 6–7 million human type II
cells were seeded into each bioreactor-mounted lobe and
cultured as described for the rat cells. Samples were harvested
at 7 days. Each sample was divided in half for RNA analysis
and histology and immunohistochemistry (IHC).
Fluorescence-activated cell sorting
Single cell suspensions were fixed in 2% paraformalde-
hyde (PFA) for 10 min at room temperature. They were
stored in 0.6% PFA at 4C for up to 2 weeks. The fixed cells
were washed with PBS, followed by incubation with pri-
mary antibodies in blocking solution (10% FBS, 0.2% Tri-
ton X-100, in PBS) for 25 min on ice. Primary antibodies
against SPC (1:500, AB3786; Millipore), AQP5 (1:100,
AB3559; Millipore), and a-SMA (1:100; Abcam) were
used. Appropriate isotypes and/or secondary controls used
included anti-mouse IgG APC (12-4714; ebiosciences) and
purified anti-rabbit IgG (02-6102; Invitrogen).
The cells were then washed twice with PBS and incubated
with species-specific secondary antibodies for an additional
25 min on ice. Finally, the cells were washed as above and
resuspended in PBS for analysis with the BD-FACS Aria.
Quantitative real-time reverse transcription
polymerase chain reaction
Quantitative real-time reverse transcription polymerase
chain reaction (qRT-PCR) was performed to determine the
expression of epithelial and mesenchymal markers. Briefly,
total cellular RNA was prepared using the RNeasy Mini Kit
following the manufacturer’s instructions (Qiagen). Single-
stranded cDNA was synthesized using the SuperScript First-
Strand Synthesis System according to the manufacturer’s
protocol (Invitrogen). An equal volume mixture of the
cDNA was used as a template for PCR amplification. All
PCR reactions were done in triplicate in a 25 mL volume
with iQ SYBR Green Supermix (Bio-Rad) and 200 nM each
of forward and reverse primers listed in Table 1. Con-
centrations of all primers were optimized before use. Real-
time quantitative PCR was performed on iCyler and iQ
software (Bio-Rad), with an initial denaturation step of
4 min at 95C, followed by 40 cycles of PCR consisting of
15 s at 95C, 30 s at 60C, and 30 s at 72C. Average
threshold cycle (Ct) values from the triplicate PCR reactions
for a gene of interest (GOI) were normalized against the
average Ct values for GAPDH from the same cDNA sample.
Fold change of GOI transcript levels between sample A and
sample B equals 2 -DDCt, where DCt = Ct(GOI) - Ct(GAPDH)
and DDCt =DCt(A) -DCt(B).
Statistical analyses
PCR data are shown as mean – SEM. Comparisons were
made with Student’s t-tests, and a p-value of < 0.05 was
considered statistically significant. Asterisks denote com-
parison with control. A single asterisk (*) indicates p < 0.05,
double asterisk (**) indicates p < 0.01.
Histology and IHC
After culture, the lobe was removed from the bioreactor
and divided approximately in half. The distal portion was
frozen for RNA analysis and the proximal portion was
inflation fixed with 10% neutral buffered formalin for 2–4 h
and transferred to 70% ethanol. The tissue was processed
and paraffin embedded. Five-micrometer sections were cut
and stained for hematoxylin and eosin (H&E) or saved for
IHC.
Tissue sections were baked for 30 min at 65C, depar-
affinized in xylenes, and rehydrated in an ethanol gradient.
Sections were subjected to heat-mediated citric acid antigen
retrieval at 75C for 25 min and cooled to room temperature.
After rinsing with PBS, sections were permeabilized with
0.2% Triton-X 100 in PBS for 10–12 min at room tem-
perature. Permeabilized sections were blocked with PBS
containing 5% BSA and 0.75% glycine for 1 h at room tem-
perature and incubated with primary antibodies overnight at
4C. Antibody for RTII-70 was applied at 1:40; pro-SPC,
1:1000; aquaporin-5, 1:1000; collagen IV, 1:500; fibronectin,
1:100; MMP-2, 1:500; a-actin, 1:1000; and vimentin, 1:200.
Table 1. Primers Used for Real-Time Quantitative
Reverse Transcription–Polymerase Chain




SPC 114 Forward: CTCCTGACCGCCTATAAGC
Reverse: TGGCCTGGAAGTTCTTGAAT
AQ5 182 Forward: CCTCTCACTGGGTCTTCTGG
Reverse: GCTCGATGGTCTTCTTCCTCT
a-ACTIN 133 Forward: GCTTTGCTGGTGATGATGCT
Reverse: GATCCCTCTCTTGCTCTGC
VIMEN 113 Forward: TGAGATCCAGAACATGAAGG
Reverse: TCCAGCAGCTTCCTGTAGGT
TGFBR 95 Forward: CTAATGGTGGACCGCAACAAC
Reverse: TGCTTCCCGAATGTCTGAC
COLIA1 97 Forward: GAGCGGAGAGTACTGGATCG
Reverse: TGGGGAACACACAGGTCTGA
MMP2 114 Forward: AGGGAATGAGTACTGGGTCTAT
Reverse: CTCCAGTTAAAGGCAGCGTCT
FIB 208 Forward: TTATGACGACGGGAAGACCT
Reverse: TAGTGTTCGTTCTCTGATGGTA
b-actin 128 Forward: GCAGGAGTACGATGAGTCCG
Reverse: ACGCAGCTCAGTAACAGTCC
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Sections were rinsed and secondaries applied at 1:500 for 1 h
at room temperature. Sections were stained with 4¢,6-diami-
dino-2-phenylindole (DAPI) and mounted with polyvinyl al-
cohol with DABCO (PVA-DABCO), coverslipped, and dried
overnight. Stained sections were imaged with a Zeiss Axiovert
zoom inverted microscope, a Hamamatsu camera, and Volo-
city software.
Results
Characterization of isolated neonatal lung cells
Isolation of RTII-70 + cells using positive selection through
the Miltenyi system yielded a mean of 40 – 20 million (SD)
RTII-70 + cells per 7-day-old pup (Fig. 1A). For a whole
litter, the average number of total RTII-70 + cells was 40
million, a yield of *8% of the total cells isolated per litter; the
initial total comprised *50% macrophages (data not shown).
The freshly isolated cells were evaluated for expression
of type II and type I epithelial cell markers at both the
protein and gene levels. We also assayed for markers of
mesenchymal cells. For type II cells, we probed for RTII-
709 and pro-SPC, an intracellular marker for type II
pneumocytes or their precursors. For type I epithelial cells,
we evaluated expression of AQP-5. By FACS (example of
a typical isolation shown in Fig. 1C), 40–52% of the mag-
netically sorted population is positive for the RTII-70. The
FIG. 1. Isolation of RTII-70 + neo-
natal epithelial cells. (A) Cells within
a mixed lung cell population are tag-
ged with a primary antibody against
RTII-70, followed by a secondary that
is conjugated to an iron oxide particle.
This allows for separation of the tag-
ged (RTII-70-positive) cells to be
separated from the overall population.
(B) Relative gene expression for al-
veolar epithelial (SPC and AQP-5)
and mesenchymal (a-actin and vi-
mentin) markers. (C) Fluorescence-
activated cell sorting (FACS) analysis
of cells separated by magnetic col-
umn. Cells are > 50% RTII-70 posi-
tive. The majority is positive for
pro-surfactant protein C (pro-SPC;
70%). Fewer than 1% of cells are
positive for a-actin. Very few are
aquaporin 5 (AQP-5) positive (4%).
Color images available online at
www.liebertpub.com/tea
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majority of the isolated cells (55–70%) are also pro-SPC + .
This portion of pro-SPC + cells is substantially greater than
that found in mixed neonatal isolates, which are obtained
by treatment with collagenase and elastase, without sorting
(data not shown). Very few of the RTII-70 antibody and
bead-isolated cells (4.0% of total) were AQP5 positive, and
the abundance of AQP5 is significantly less than that of SPC
at the RNA level ( p = 0.0052; Fig. 1B).
Only < 1% of cells were positive for alpha smooth muscle
actin by FACS (Fig. 1C). Comparatively, normal mixed
cell isolation obtained after elastase/collagenous digestion
without sorting includes up to 30% a-actin-positive cells by
FACS analysis (data not shown). To further evaluate mes-
enchymal cell phenotypes, we performed RT-PCR for alpha
actin and vimentin.15 Gene expression of both a-actin and
vimentin in the bead-sorted cell population is significantly
lower than expression of SPC, but not completely absent (Fig.
1B). Expression of a-actin is 13-fold less than that of SPC,
( p = 0.0072) and expression of vimentin is 6-fold less ( p = 0.01).
Taken together, these data indicate that magnetic bead
isolation for RTII-70 allows for the enrichment of distal
lung epithelial cells when compared with whole lung iso-
lates. Use of the RTII-70 surface marker and magnetic bead
separation also allows for enrichment of distal epithelium
and depletes cells that express mesenchymal cells.
Culture of isolated neonatal RTII-70 + cells
on decellularized matrices that are mounted
in a bioreactor
To evaluate the initial distribution of cells within the
scaffold and their ability to selectively populate anatomi-
cally appropriate regions of the lung, we assessed the lo-
cation and density of cells over time. Rat lungs were
decellularized to remove cellular components and visible
nuclei (Fig. 2A, B). After initial seeding and 1 day of cul-
ture, cells are noted throughout the alveoli, both as single
cells and clusters (Fig. 2C, inset). These cells do not inhabit
the small airways (Fig. 2D, arrow), nor do they enter the
vascular compartment. Hence, this observation confirmed
prior speculation from our group, and others that epithelial
cells reintroduced into an acellular tend to home to correct
anatomic locations within the scaffold. Cells exhibit a
rounded or cuboidal morphology (Fig. 2C, inset). After 7
FIG. 2. Hematoxylin and
eosin (H&E) stains of native,
decellularized, and re-
populated lung. (A) Native
lung. (B) Decellularized
lung. (C) Alveolar areas of a
lung scaffold seeded with
RTII-70 + cells and cultured
for 1 day in Dulbecco’s
modified Eagle’s medium
(DMEM) + 10% fetal bovine
serum (FBS) with pulsatile
perfusion at 1 mL/min. 1E7
cells were seeded in the up-
per right lobe of the decel-
lularized lung; inset shows
high magnification of cells
adhering to the basement
membrane of an alveolus.
(D) Small airway (arrow)
of the lung scaffold depicted
in (B) shows no cellular
repopulation of this structure.
(E) An acellular scaffold after
seeding with RTII-70 + cells
and cultured for 7 days; inset
shows high magnification for
distinction of cell morphology
after 7 days of culture. (F)
RTII-70 + cells after 7 days
of culture on decellularized
lung. Eosinophilic foci are
indicated (chevrons). Scale
bars = 100mm. Scale bars,
insets = 25mm. Color images
available online at www
.liebertpub.com/tea
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days in culture, the cells cover the ECM more densely and
with a more even distribution (Fig. 2E). Some cells appear
to adopt a more elongated phenotype (Fig. 2E, inset). Dense
areas of eosinophilic matrix are also present at day 7 (Fig.
2F, chevrons).
Immunostaining of the native and repopulated lung re-
vealed that the cultures stain positively for RTII-70 at day 1
in approximately anatomically correct locations (Fig. 3A, D,
inset of D), but this expression is lost after 7 days in culture
(Fig. 3G, inset). Pro-SPC appears abundant and appropri-
ately organized, as characterized by punctate surfactant
staining throughout the cytoplasm at day 1 (Fig. 3B, E, inset
of E). After 7 days in culture, however, the appearance of
positive pro-surfactant protein becomes more diffusely dis-
tributed throughout the cytoplasm and is diminished in in-
tensity, likely reflecting a nonfunctional phenotype (Fig. 3H,
inset). Indeed, diffuse cytoplasmic staining of SPC is asso-
ciated with surfactant dysfunction disorders, often as a result
of trafficking abnormalities.16 Expression of AQP-5 is scant
at day 1 compared with native lung (Fig. 3C, F, inset) and is
completely absent at day 7 by immunofluorescence (Fig. 3I,
inset). These data suggest that the epithelial cells that ini-
tially displayed markers of type II alveolar epithelial cells
are not only no longer functional type II cells but that they
are also not losing this phenotype in favor of expected
progeny such as type I epithelial cells.
FIG. 3. Expression of alveolar epithelial markers. (A–C) Native lung stained for RTII-70 (RTII-70, A), pro-SPC (B), or
AQP-5 (C). (D–F) Day 1 culture of RTII-70 isolate on decellularized lung stained for RTII-70 (D), pro-SPC (E), or AQP-5.
(G–I) RTII-70 culture after 7 days stained for RTII-70 (G), pro-SPC (H), or AQP-5 (I). Insets are provided in (D–I) for
visualization of cell morphology at high magnification. Antigen of interest is shown in red or green [one color per panel or
inset, with the exception of inset in (E); color of interest in inset E is green]. Nuclei are stained with 4¢,6-diamidino-2-
phenylindole (DAPI; blue). Scale bars = 20mm (A–C); 50 mm (D–I). Scale bars, insets = 25 mm. ( J, K) Gene expression by
quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) for SPC (J) or AQP5 (K). Gene ex-
pression was normalized to GAPDH and is expressed as a ratio between the samples of interest and day 0 levels. Fold
change is on the y-axis. Sample is indicated below the x-axis. n = 3 independent samples. Values are normalized and
compared with day 0 (freshly isolated) cells. p < 0.05 is indicated by a single asterisk; p < 0.01 is indicated by two asterisks,
as determined by Student’s t-test. Color images available online at www.liebertpub.com/tea
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qRT-PCR analysis for SPC demonstrates an *100·
decrease in SPC expression after 1 day in culture and
nearly 6000· fold decrease by day 7 (Fig. 3J). For AQP-5,
expression declines 2 and 250-fold at days 1 and 7, re-
spectively, compared with the initial isolated population
(Fig. 3K). This suggests a loss of any type I cells initially
present and also implies an overall deficiency in type II
cells differentiating to type I cells. In sum, these data in-
dicate a loss of definitive epithelial cell markers after
culture on the acellular scaffold under these culture con-
ditions (DMEM + 10% FBS, with perfusion of the scaffold
with culture medium, but with no ventilation).
Human type II cells cultured on decellularized scaffolds
mimic the loss of epithelial markers exhibited by rat
distal epithelial cells
Interestingly, human type II epithelial cells that are cul-
tured on decellularized rat matrices displayed a trend in
appearance and protein expression that is similar to the rat
epithelial cell cultures. As observed in rat RTII-70 cultures,
on H&E staining, the human cells were spread over a large
portion of the total scaffold (Fig. 4A, B). The presence of
elongated cells was noted as they were in the rat cell cul-
tures, but there were also still many cells that displayed a
more rounded or cuboidal morphology reminiscent of an
epithelial phenotype (Fig. 4A, B, inset of B). Like the rat
RTII-70 cultures, there were also areas of dense eosinophilic
matrix present after 7 days of culture (Fig. 4B, chevrons).
Immunostaining in 7-day cultures was performed for pro-
SPC, for thyroid transcription factor-1 (TTF-1), and T1a, a
marker of type I epithelial cells. At the 7-day time point,
pro-SPC was located somewhat diffusely throughout the
cytoplasm of the cells in the scaffold, but had not lost as
much intensity in the staining as the rat cells did (Fig. 4C,
inset). TTF-1 was found localized to the nucleus in a few
rare cells in 7-day cultures (Fig. 4D, arrows and inset), but
not in the majority of the population. Additional nonspecific
or diffuse cytoplasmic staining is also seen. There was no
evidence of T1a staining (data not shown).
Rat epithelial cells gain expression
of mesenchymal markers
We assayed cultures of rat epithelial cells over time for
the mesenchymal markers, a-actin, vimentin, and TGF-b
receptor I. The type I TGF-b receptor is not constitutively
active, but forms a heterodimer with the constitutively ac-
tive type II receptor when it binds to TGF-b. An active
TGF-b I receptor is required for phosphorylation and acti-
vation of Smad proteins, which are thought to be key me-
diators of epithelial–mesenchymal transition (EMT). In
contrast to the diminished expression of epithelial markers
in our system, mesenchymal markers show increased ex-
pression in samples of rat cells cultured on the decellular-
ized matrix at both the protein and RNA levels. Staining of
FIG. 4. H&E and immunofluorescent staining for epithelial markers in human type II cells cultured on acellular rat lung
matrix. (A) H&E of human type II cells cultured on a decellularized rat lung scaffold mounted in a bioreactor and cultured
in DMEM + 10% FBS with pulsatile perfusion at 1 mL/min for 7 days. (B) Low-magnification H&E of human type II cells
cultured on an acellular scaffold for 7 days to show overall distribution. Dense areas of eosinophilic material are indicated
(chevrons). Inset is provided for high magnification. (C) Human type II 7-day culture stained for pro-SPC (green in main
panel; red in inset). (D) Human type II 7-day culture stained for thyroid transcription factor-1 (TTF-1; green in main panel,
red in inset). Nuclei are stained with DAPI (C, D). Arrows indicate nuclear localization of TTF-1. Scale bars = 100mm (A),
200 mm (B), 250mm (C, D). Scale bars, insets = 25 mm. Color images available online at www.liebertpub.com/tea
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rat cell cultures for a-actin, largely absent at day 1, in-
creases dramatically by day 7 (Fig. 5C, E, with corre-
sponding high-magnification inset panels; Fig. 5A shows
native rat lung stained for a-actin). After 7 days in culture,
nearly all of the rat cells within the lung are a-actin pos-
itive. Gene expression in these samples indicates an in-
crease in a-actin of approximately five-fold ( p = 0.00049)
after 1 day in culture and eight-fold by day 7 ( p = 1.4E-10;
Fig. 5G).
Vimentin expression is already apparent and quite abun-
dant after 1 day in culture, at both the protein (Fig. 5D, inset,
similar to native lung Fig. 5B) and gene levels for these cells
(Fig. 5H). Gene expression of this cytoskeletal component
increases by 2.6-fold ( p = 0.00055) after 1 day in culture. By
day 7, vimentin transcript expression decreases relative to
day 1 and is not significantly different from expression
levels found in freshly isolated cells ( p = 0.16). However,
vimentin protein persists at levels detectable by immuno-
fluorescence (Fig. 5F, inset). Transcript levels for TGF-bR
increase after 1 day in culture compared with freshly isolated
cells ( p = 2.3E-5) and remain significantly elevated at day 7
( p = 0.00021; Fig. 5I). Taken together, these data suggest that
the cells seeded into the scaffold at day 0 undergo EMT that
begins as early as 1 day in culture.
FIG. 5. Expression of mesenchymal
markers. (A, B) Native lung stained
for a-actin (A) or vimentin (B). (C, D)
One-day cultures of RTII-70 isolate
on decellularized lung stained for a-
actin (C) or vimentin (D). (E, F) Se-
ven-day cultures of RTII-70 isolate on
decellularized lung stained for a-actin
(E) or vimentin (F). Insets are in-
cluded in (C–F) to provide visualiza-
tion of cell morphology at high
magnification. Antigens of interest are
in red. Nuclei are counterstained with
DAPI (blue). Scale bars = 50mm (A–F).
(G–I) qRT-PCR gene expression for
a-actin, vimentin, and TGF-b recep-
tor. Gene expression was normalized
to GAPDH and is expressed as a ratio
between the samples of interest and
day 0 levels. Fold change is on the
y-axis. Sample is indicated below the
x-axis. n = 3 independent samples.
Values are normalized and compared
with day 0 (freshly isolated) cells.
p < 0.01 is indicated by two asterisks,
as determined by Student’s t-test. ns,
no significant difference. Scale bars,
insets = 25 mm. Color images available
online at www.liebertpub.com/tea
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Human epithelial cells express the mesenchymal
marker, vimentin, and the signal transduction
molecule, pSmad2
In contrast to the expression of a-actin by rat epithelial
cells in culture, human type II cells cultured on the decel-
lularized rat matrix were negative for the mesenchymal
protein, a-actin, after 7 days in culture (Fig. 6A). However,
there was some expression of vimentin, another cytoskeletal
protein associated with mesenchymal cells after 7 days in
culture (*40–50% of all cells; Fig. 6B). Approximately half
of the human cells cultured in the decellularized matrix were
PCNA positive, indicating that there is a proliferative frac-
tion in the population (Fig. 6C). Finally, human type II cells
cultured in the decellularized matrix show nuclear locali-
zation of the phosphorylated signal transduction molecule,
Smad2 (pSmad2; Fig. 6D–F). Nuclear localization of the
phosphorylated form of this molecule is a direct result of
active TGF-b signaling. Therefore, these data suggest that
the human epithelial cells in these cultures are binding TGF-
b in culture likely from serum, thereby activating the ALK5
signaling pathway.
Rat cells and the ECM
A switch to a mesenchymal phenotype can also be driven
by ECM components. To further characterize and evaluate
the interaction of the cells with the ECM, we evaluated the
distribution and abundance of the key ECM proteins and
matrix metalloproteases by immunostaining for fibronectin,
collagen IV, and MMP-2. Fibronectin and MMP-2 were
also evaluated by gene expression. Collagen I abundance
was assessed at the transcript level only.
Fibronectin is a key component of the provisional matrix
that epithelial cells adhere to and migrate over during
wound healing.17,18 It also accumulates at the site of injury
during a fibrotic response.19 After 1 day in culture in our
system, there is little fibronectin apparent (Fig. 7D). At this
short time point, any fibronectin that is there is likely from
the serum-containing culture medium since serum has high
levels of soluble fibronectin.2 However, gene expression for
fibronectin does increase by day 1 ( p = 0.0135; Fig. 7K), and
by day 7, there appears to be an increase in protein ex-
pression as well, especially in areas highly populated by the
rat cells cultivated within the matrix (Fig. 7G).
Collagen IV is a key basement membrane protein (Fig.
7B, E, H),20,21 and MMP-2, also known as gelatinase A or
type IV collagenase, breaks down this matrix component.
Epithelial cells do not constitutively express this enzyme.
Accordingly, neither native lung samples (Fig. 7C) nor day
1 cultures (Fig. 7F) contain positive MMP-2 staining. By
day 7, however, there is decreased immunostaining for
collagen IV and positive staining for MMP-2 (Fig. 7H, I).
Therefore, this enzyme activity is acquired over time in
culture. Gene expression for MMP-2 indicates a significant
increase at day 1 ( p = 0.0128), followed by a decline to
initial cell isolate levels by day 7 ( p = 0.3840; Fig. 7L). By
day 7, immunostaining for collagen IV has a degraded ap-
pearance indicative of ongoing matrix breakdown, while
MMP2 is widely expressed by immunostaining. In contrast,
expression of the collagen I gene increases over time and
remains significantly elevated at day 7 compared with cell
isolates ( p = 0.0016; Fig. 7J), implying ongoing deposition
of this matrix protein that is typically deposited by mesen-
chymal cells.
FIG. 6. Mesenchymal markers and nuclear markers in human type II cell cultures. (A) Human type II culture stained for
a-actin (red) after 7 days of bioreactor culture with pulsatile perfusion at 1 mL/min. (B) Human type II culture stained for
vimentin (red). (C) Human type II culture stained for proliferating cell nuclear antigen (PCNA; red). (D) Human type II
culture stained for phosphorylated Smad2 (pSmad2); red channel is displayed. (E) DAPI nuclear counterstain for pSmad2
staining. (F) Overlay of pSmad2 and DAPI for human type II culture at 7 days. Nuclei are stained with DAPI (A–C, E, F).
Scale bars = 250 mm (A), 25mm (B–F). Color images available online at www.liebertpub.com/tea
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Discussion
Type I and type II alveolar epithelial cells are critical to the
generation of functional lung tissue. In our prior studies,
seeding of acellular rat lung scaffolds with mixed populations
of neonatal rat lung cells (containing SPC-, CCSP- CD31-,
and alpha-actin-positive cells) resulted in region-specific
matrix repopulation and overall retention of epithelial cell
phenotypes and markers. Studies with isolated rat type II
cells on decellularized human matrix by Lwebuga-Mukasa
et al. demonstrated a shift from a type II phenotype to a
cell type with a more flattened morphology than that of a
typical cuboidal type II cell; the cells cultured by this group
also demonstrated reduced phospholipid production.8 Lack-
ing additional information, the authors concluded that this
change in cell type might be a recapitulation of the differ-
entiation of type II cells to type I cells that has been observed
in vivo after injury.
In this study, seeding a population of distal lung cells that
are enriched for type II alveolar epithelial marker, RTII-70,
into a decellularized scaffold and culturing the construct for
up to 7 days resulted in a similar flattening change in
morphology as well as diminished pro-SPC production.
However, evaluation of the cells by protein and RNA indi-
cates that the cells lose expression of alveolar epithelial
markers and gain near-universal expression of mesenchymal
markers after 7 days. These changes were noted qualitatively
by immunostaining and quantitatively using qRT-PCR. Based
upon these observations and the very scant proportion of
alpha-actin-positive cells in the initial cell population, we
hypothesize that these cells undergo an epithelial-to-mes-
enchymal transition when seeded into the lung matrix as a
FIG. 7. Extracellular matrix staining and gene expression for native lung and RTII-70 cultures after 1 and 7 days. (A)
Immunofluorescence of native lung stained for fibronectin (red). (B) Native lung stained for collagen IV (red). (C) Native
lung stained for matrix metalloprotease-2 (MMP-2). (D–F) One-day culture of RTII-70 isolate on decellularized lung
stained for fibronectin (D), collagen IV (E), or MMP-2 (F). (G–I) Seven-day culture of RTII-70 isolate on decellularized
lung stained for fibronectin (G), collagen IV (H), or MMP-2 (I). All antigens of interest are shown in red. Nuclei are stained
with DAPI (blue). Scale bars = 50 mm (A–I). ( J–L) Gene expression by qRT-PCR for collagen I ( J), fibronectin (K), and
MMP-2 (L). Gene expression was normalized to GAPDH and is expressed as a ratio between the samples of interest and day
0 levels. Fold change is on the y-axis. Sample is indicated below the x-axis. All values are normalized to day 0 (freshly
isolated) cells. n = 3 independent samples. Values are normalized and compared with day 0 (freshly isolated) cells. p < 0.05
is indicated by a single asterisk; p < 0.01 is indicated by two asterisks, as determined by Student’s t-test. Color images
available online at www.liebertpub.com/tea
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purified cell source. Although similar in appearance to the
flattened morphology of a type I-like cell, the resulting
mesenchymal phenotype is different from that of an epi-
thelial or epithelial-like cell. This has functional conse-
quences both for repopulating the alveolar compartment
with the aim of creating functional lung tissue that can ex-
change gas and for the impact that these cells have on the
architecture of the scaffold in which they reside.
Of the mesenchymal markers investigated here, vimentin
is the first to be detected at the protein level. After 1 day in
culture, a large portion of the total cells that are distributed
within the scaffold are vimentin positive. Although other
mesenchymal markers are not widely expressed at the pro-
tein level until day 7, this time frame for vimentin is con-
sistent with in vitro studies of induced EMT. In prior
studies, alveolar type II cells isolated from adult Sprague-
Dawley rats express vimentin protein within 4 h of treatment
with TGF-b, and by 24 h, most cells possessed intact vi-
mentin filament networks.22 In response to soluble collagen
IV, another EMT stimulus, human mammary epithelial cells
and breast cancer cells have increased vimentin protein
expression by 3 h.23 Therefore, these data suggest that the
epithelial cells that are seeded onto the decellularized matrix
may have already initiated an EMT program after 1 day and
that the vimentin present at the gene and protein levels is the
harbinger of this process.
Overall, the loss of an epithelial phenotype of cells cul-
tured on the acellular matrix was somewhat unexpected.
Compared with culture of primary epithelial cells on tissue
culture plastic, the decellularized lung matrix is softer and
contains more tissue-specific proteins. Both of these factors
have been shown to promote the tissue-specific cell phe-
notype and function.24–28 Clearly, in the experiments pre-
sented here, the ECM is not sufficient under the culture
conditions used (DMEM + 10% FBS, perfusion, no venti-
lation) to maintain neonatal, rat lung epithelial phenotypes.
Instead, these cells appear to undergo an EMT. Two key
differences between prior studies and the studies presented
here include the use of ventilation and of a more highly
mixed cell population.
Lack of ventilation in these studies compared with whole
lung experiments reported previously2 may be significant as
the benefits of stretch on epithelial phenotypes are well
documented. Early lung development is characterized by
fetal breathing movements (FBM) that keep the lung ex-
panded to a volume up to twice that of postnatal functional
residual capacity,29 and lack of FBM leads to lung hypo-
plasia during development.30 Additionally, distension favors
expression of the type I alveolar epithelial cell phenotype,
the cells most important for gas exchange in the lung,31
while variable stretch can increase surfactant secretion by
type II alveolar epithelial cells.32 In our system, ventilation
with culture medium may also confer benefits with respect
to nutrient and oxygen transport. This may have played a
role in the observed EMT as physiological stress and hyp-
oxia may be involved in inducing EMT.
In addition to the role played in cellular phenotypic
maintenance by ventilation, the medium and the compo-
nents included or absent in it may also play a role in the
observed phenotypic shift. The presence of TGF-b in se-
rum is known to be present at concentrations of up to 2 ng/
mL of TGF-b in DMEM containing 10% FBS.33 This is the
same concentration of TGF-b used by Rogel et al. to in-
duce EMT in rat type II cells isolated from adult Sprague-
Dawley rats.22 Previous studies have shown that the ad-
dition of TGF-b to isolated rat type II cells cultured
in vitro, or to bronchial epithelial cells, leads to EMT.
Conversion of the type II cells to a mesenchymal pheno-
type occurred within 6 days.34 Bronchial cells maintained an
epithelial phenotype after 1 day in culture with TGF-b, but
adopted a spindle-shaped morphology and showed increased
expression of mesenchymal markers at 7 days.35 In a mouse
model of pulmonary fibrosis that relies on overexpression of
active TGF-b, clusters of X-gal (to identify cells of epithelial
origin) and a-smooth muscle actin-positive cells are frequently
located in areas of dense fibronectin deposition, and when
isolated murine type II epithelial cells were cultured in vitro
on fibronectin, they underwent EMT through avb6 integrin
activation of secreted latent TGF-b.36
In contrast, the presence of all-trans retinoic acid, a common
component of media used to support epithelial phenotypes,
can limit the levels of phosphorylated Smad 2 and 3 that are
induced by active TGF-b1 in differentiating hematopoietic
cells.37 BMP-7 is also a candidate for prevention of EMT
through TGF-b inhibition. Studies show that BMP-7 can inhibit
TGF-b-induced EMT in renal fibrosis,38 although reports of
efficacy in models of pulmonary fibrosis are mixed.39,40 Miti-
gating these observations regarding TGF-b, however, is the fact
that our prior studies of cell culture on rat lung scaffolds also
utilized DMEM with 10% serum, and in the case of mixed
epithelial cultures, we did not observe EMT as described here.
Hence, if TGF-b is causative, it is likely in concert with another
cue such as lack of (some unknown) supporting cell types that
were present in mixed cultures, yet lacking in purified RTII-
70 + populations.
Finally, ECM components are nontrivial constituents of the
microenvironment. Both native collagen IV and fibronectin
can induce EMT in epithelial cells. Treatment of epithelial
cells with soluble native collagen IV induces NF-kB activation
and an increase in MMP-2 secretion.23 Fibronectin, although
minimally present in the scaffold used here,2 is present in
soluble form in FBS. Fibronectin can induce EMT through
activation of the a6b4 integrin, which activates latent TGF-b
that then acts on the overlying epithelial cells.36 In the absence
of other potent stimuli such as ventilation or paracrine factors,
the soluble fibronectin, or the possibly fragmented collagen IV
in the acellular matrix, may become a dominant factor in
driving a mesenchymal phenotype.
The human type II cells cultured on the decellularized
lung matrix have a similar appearance to the rat RTII-70 +
isolate cultured on the decellularized matrix. Based on the
immunostaining, however, it appears that these cells do not
completely transition from an epithelial to a mesenchymal
phenotype over the 7 days of these experiments. This may be
due to the difference in age of the cells. Human type II cells
were obtained from 50 to 60 year olds, while the rat type II
cells are from neonates and hence may have more plasticity.
Indeed, alveolar development in rats occurs primarily post-
natally, and so is underway at the time the RTII-70 + cells are
isolated. Alternatively, differences in the isolation procedures
used to obtain rat and human cells may explain the differ-
ential expression of epithelial and mesenchymal markers.
With respect to composition of the population, there are
some caveats of the rat epithelium-enriched population
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described in these studies. First, although type II pneumo-
cytes make up the majority of the population, as indicated
by the RTII-70 + population, they are not the sole cell type
in these isolates. This leaves the possibility that instead of
cells that undergo a shift from an epithelial to a mesen-
chymal phenotype, the observed increase in mesenchymal
gene and protein expression may reflect overgrowth of ex-
isting a-actin-positive cells, although not all cells are PCNA
positive (data not shown). With regard to type II alveolar
epithelial cells, even if the population was 100% RTII-70 +
cells, recent evidence has demonstrated the heterogeneity of
type II cells,41 which may mean that some cells have a
greater capacity for regeneration than others. Parsing out
type II subpopulations and their potential role in EMT and
matrix production, as opposed to tissue regeneration, may be
an interesting source of inquiry in the future. The use of
lineage-traced SPC-cre/reporter mouse cells to definitively
show that the originating cell that gives rise to the mesen-
chymal cells observed at day 7 is, indeed, of type II epi-
thelial origin would also be of interest.
In summary, we have demonstrated the isolation of a
population of neonatal rat lung cells enriched for type II
epithelial cells or their progenitors by the use of the RTII-70
surface antibody. We seeded these cells into a decellularized
lung scaffold and cultured them for 1 or 7 days. During this
time, the cells appear to have undergone EMT, which may
be part of a wound-healing or Type 2 EMT response. In the
quest to reconstitute functional lung tissue, this work rep-
resents a new element of cell–cell and cell–matrix interac-
tions that should inform future studies of epithelial and
perhaps endothelial cells aimed at repopulating whole lung
scaffolds. Further investigation should focus on both shorter
and longer time points than those reported here (hours, days
14 and 21). In addition, the impact of media components
and physical stimuli such as ventilation are important ave-
nues for additional study. Understanding each of these
components in greater depth should improve our ability to
refine our cell source selection as well as aid in the selection
and delivery of cues required for appropriate cell and tissue
organization and function.
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